Vitae Pharmaceuticals, Inc
Vitae Pharmaceuticals, Inc (VTAE) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 104 transactions totaling $48.3M, demonstrating a bullish sentiment with $898.8K in net insider flow. The most recent transaction on Oct 25, 2016 involved a transaction of 828 shares valued at $17.4K.
VTAE Insider Activity Summary
Who Is Buying VTAE Stock?
No significant insider buying has been recorded for VTAE in the recent period.
Who Is Selling VTAE Stock?
No significant insider selling has been recorded for VTAE in the recent period.
Is Vitae Pharmaceuticals, Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VTAE is bullish with an Insider Alignment Score of 51/100 and a net flow of $898.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VTAE Frequently Asked Questions
Understanding VTAE Insider Activity
Insider trading at Vitae Pharmaceuticals, Inc (VTAE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading VTAE stock, having executed 104 transactions in the past 90 days. The most active insider is Capital Partners, L.p. Adage (Executive), who has made 1 transactions totaling $21.4M.
Related Tools
Track Vitae Pharmaceuticals, Inc Insider Activity
Get notified when executives and directors at VTAE file new Form 4 transactions